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Introduction: Burkitt’s lymphoma is a highly aggressive, small, non-cleaved B-cell non-Hodgkin's lymphoma. In the
sporadic form of the disease that occurs in non-endemic areas around the world, most commonly in developed
countries, patients usually present with an abdominal mass that frequently involves the ileocecal region of the
bowel; ocular or orbital involvement is rare. Primary disease of the sinuses is uncommon and, to the best of our
knowledge, that of the anterior septum has never been described. We report the diagnosis and successful
management of Burkitt’s lymphoma originating from the nasal septum in a male patient.
Case presentation: An otherwise healthy 78-year-old Caucasian man who did not smoke cigarettes was admitted
to our Ear, Nose and Throat outpatient clinic with the complaint of nasal obstruction due to left-sided nasal septal
thickening. Paranasal computerized tomography revealed a well-circumscribed solid mass originating from his
anterior nasal septum and obstructing his airway. The final diagnosis of Burkitt’s lymphoma was verified by
immunohistochemical studies. Our patient had a good clinical outcome after chemoradiotherapy, with no
problems reported to date in the second year of follow-up.
Conclusion: We provide what we believe to be the first report of a case of sporadic Burkitt’s lymphoma involving
the nasal septum, and describe the efficacy of first-line chemotherapy. Being an original case report with broader
clinical impact across more than one area of medicine, this case presentation has the potential to significantly
advance our understanding of Burkitt’s lymphoma and we emphasize the need to include this disease in the
differential diagnosis of patients presenting with a nasal septal mass.Introduction
Burkitt’s lymphoma (BL) is a highly aggressive, small,
non-cleaved B-cell non-Hodgkin's lymphoma that was
first described in 1958 as a mandibular malignancy in
African children and classified as a mature B-cell neo-
plasm under the World Health Organization classifica-
tions [1,2]. BL is endemic in certain regions of equatorial
Africa, where it commonly involves facial bones, such as
the mandible, maxilla and orbit, and can invade adjacent
orbital soft tissue structures, such as the eye [3,4]. In the
sporadic form of the disease that occurs in non-endemic
areas around the world, most commonly in developed
countries, patients usually present with an abdominal
mass that frequently involves the ileocecal region of theCorrespondence: cgaslan@hotmail.com
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reproduction in any medium, provided the orbowel [5]; ocular or orbital involvement is rare [6]. Pri-
mary disease of the sinuses is uncommon and, to the
best of our knowledge, that of the anterior septum has
never been described. We describe the case of a patient
with sporadic BL originating from his nasal septum,
leading to the complaint of nasal obstruction due to left-
sided nasal septal thickening, who responded well to
chemotherapy.Case presentation
An otherwise healthy 78-year-old Caucasian male patient
who did not smoke cigarettes presented to our Ear, Nose
and Throat outpatient clinic with the complaint of nasal
obstruction. A physical examination revealed a smooth
surfaced mass occluding his left nasal orifice with right-
ward deviation of his nasal septum. Paranasal compute-
rized tomography (CT) revealed a well-circumscribedis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Histopathology demonstrated medium to large
atypical lymphocytes and a ‘starry sky’ pattern of small,
undifferentiated, tightly packed lymphocytes interspersed with
large pale histiocytes (hemotoxylin-eosin, ×400).
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obstructing his airway (Figure 1). A histopathologic eva-
luation of a specimen obtained via an incisional punch
biopsy identified mucosal infiltration by lymphoid cells
with small round nuclei and nucleoli and a ‘starry sky’
pattern of small, undifferentiated, tightly packed lympho-
cytes interspersed with large pale histiocytes (Figure 2).
Following oncology consultation, a final diagnosis of stage
3 (Ann Arbor Staging System) BL was made and verified
by immunohistochemical studies. BL, regardless of sub-
type, typically expresses monotypic surface immuno-
globulin M and pan-B-cell antigens, including cluster of
differentiation (CD)19, CD20, CD22 and CD79a, and
co-expresses CD10, B-cell lymphoma 6 protein, CD43
and protein 53, but not CD5, CD23, B-cell lymphoma 2
protein, CD138 or terminal deoxynucleotidyl transfer-
ase. A test for human immunodeficiency virus revealed
that our patient was seronegative for the virus; a titer
for Epstein-Barr virus (EBV) was also negative and his
lactate dehydrogenase level was elevated.
Eight scheduled cycles of chemotherapy as a first-line
treatment with a combination of doxorubicin, vincristine,Figure 1 Coronal view on computed tomography showing a
well-circumscribed septal mass.cyclophosphamide and prednisone were administered.
Our patient received no radiotherapy sessions because
control positron emission tomography imaging performed
after the chemotherapy revealed no pathological findings.
Post-treatment controls revealed a loss of overall tumor
mass with no obstruction in both his nasal orifices. Due to
identification of the well-circumscribed anterior mass, the
control CT was not considered necessary. Our patient
had a good clinical outcome after the chemotherapy and
has reported no problems to date in the second year of
follow-up.
Discussion
Currently classified as a mature B-cell neoplasm under
the World Health Organization classifications, BL was
first described as a mandibular malignancy and docu-
mented in sub-Saharan Africa in a pediatric population
[1,2]. It is now recognized to occur in three major vari-
ants. The endemic (African) form occurs in regions of
equatorial Africa, in association with EBV infection in
95% of cases, and commonly involves facial bones [3,4].
The immunodeficiency-associated form occurs as a mani-
festation of human immunodeficiency virus infection and
acquired immunodeficiency syndrome [7,8]. Finally, the
sporadic (North American) form occurs in non-endemic
areas around the world, where it typically manifests as an
abdominal tumor [9]. Indeed, this small, non-cleaved B-
cell lymphoma accounts for between 40% and 50% of
childhood non-Hodgkin’s lymphomas in non-endemic
areas [10,11], whereas the sporadic form in adults ac-
counts for 1% to 2% of all adult lymphomas in western
Europe and the United States [12].
Although BLs occurring in non-endemic areas are
identical to those in endemic areas on histology, BL will
often present differently depending upon the variant
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features but an unusual presentation of sporadic BL, ori-
ginating from the anterior nasal septum in a 78-year-old
male patient, support that BL, as a mature B-cell non-
Hodgkin's lymphoma, is a monoclonal proliferation of
B-lymphocytes that can arise from any location in the
body and demonstrates the ‘starry sky’ pattern of lym-
phocytes on histologic examination [6].
To the best of our knowledge, our case seems to be
the first report of a nasal septal origination of sporadic
BL in adults, as the lymphoma tends to arise in the
lymphoid tissues of the gut and the upper respiratory
tract, often presenting as masses in the Waldeyer ring or
the terminal ileum, or even with massive abdominal in-
volvement [12].
Given that primary sinonasal non-Hodgkin's lymph-
omas usually manifest with symptoms mimicking chro-
nic sinusitis, including nasal obstruction, headache and
post-nasal drip [13-15], the diagnostic work up should
include appropriate laboratory investigation for diffe-
rential diagnosis, and detailed CT imaging for an accu-
rate identification of the location and extent of the
tumoral mass to guide a biopsy. The most important
diagnostic criteria is tissue diagnosis, after which all
these investigations could be performed.
Although treatment is planned according to histopa-
thologic subgroups, chemotherapy with a combination
of cyclophosphamide, vincristine, methotrexate and
prednol has been considered as the preferred thera-
peutic option in BL regardless of the stage of the
disease. The efficacy of high dose cyclophosphamide,
which achieves a treatment response in 80% to 95% of
patients with endemic BL, has led to it being considered
the cornerstone of treatment, either as a monotherapy
or in combination with other chemotherapeutic agents
[9]. Radiotherapy is considered to be not effective per
se, but it can be added to the treatment plan according
to the location of the tumor [16].
The prognosis for many patients with BL has changed
significantly with the introduction of short, intensive che-
motherapeutic regimens that have excellent response
rates, with a 92% two-year event-free survival for chil-
dren and adults with small non-cleaved lymphoma [12].
The selection of first-line chemotherapy with a combin-
ation of doxorubicin, vincristine, cyclophosphamide and
prednisone followed by the radiotherapy in our case
resulted in the complete cure of our patient with no
problems encountered within the two-year follow-up.
In addition, given that the relationship of sporadic BL
and EBV is controversial, with an indication that pa-
tients with EBV antibody positivity have better out-
comes [17,18], it is of note that our patient had negative
EBV titers which seems to be associated with a good
prognostic outcome.Conclusion
We provide what we believe to be the first report of a
case of sporadic BL involving the nasal septum. Our
findings emphasize that, in patients presenting with a
nasal septal mass, BL should be considered in the differ-
ential diagnosis and that a punch biopsy rather than
total septal excisional biopsies should be performed in
the case of septal tumors. First-line chemotherapy seems
to be an effective therapeutic option in BL, and avoids
permanent septal perforation and related unnecessary
surgical approaches. Being an original case report with
broader clinical impact across more than one area of
medicine, this case presentation has the potential to sig-
nificantly advance our understanding of BL in terms of
the differential diagnosis of patients presenting with a
nasal septal mass.
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